Authors
Latest:
Kathryn Davis, MD, MSTR: Off-Label Clobazam Use in Refractory EpilepsyThe associate professor of neurology and medical director of the epilepsy monitoring unit and Penn epilepsy surgical program at the University of Pennsylvania discussed the findings of a single-center review of off-label clobazam use for patients with drug-refractory epilepsy.
Latest:
Dennis Lal, PhD: The Value of Genetic TestingIn an interview with NeurologyLive, Dennis Lal, PhD, discusses the value of genetic testing and how it can optimize the way we develop clinical trials and test new therapies.
Latest:
The Changing Landscape of Preventative Migraine TreatmentsA panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Latest:
Therapeutic Optimization of Stiripentol for Dravet Syndrome: James Wheless, MD, FAAP, FAAN, FAESThe Le Bonheur Chair in Pediatric Neurology at the University of Tennessee Health Science Center highlighted the benefits and challenges of using stiripentol, an FDA-approved treatment for Dravet syndrome. [WATCH TIME: 4 minutes]
Latest:
Stroke Risk Increase in Women With Elevated Lifetime Estrogen ExposureResults from a recent study suggest that greater cumulative exposure to estrogen throughout a woman’s lifespan could increase her risk of stroke.
Latest:
Advancing the Treatment of Pediatric Migraine With Nerivio REN Wearable: Klaus Werner, MD & Alon IroniThe pediatric neurologist at Duke Health and chief executive officer at Theranica talked about a remote electrical neuromodulation wearable that showed promising results for the treatment and prevention of migraine in pediatric patients. [WATCH TIME: 5 minutes]
Latest:
The Approval of Fenfluramine for Treating Dravet SyndromeTwo experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.
Latest:
Building a Neurology Space Inclusive of Diversity and Equity: Daniel Correa, MD, MScThe neurologist at Montefiore Medical Center, Albert Einstein College of Medicine, discussed his experience in establishing a neurology department committee on diversity, equity, and inclusion. [WATCH TIME: 5 minutes]
Latest:
Elizabeth Gerard, MD: Considering Genetic Testing for Adult EpilepticsThe associate professor of neurology and director of the Women With Epilepsy Program at Northwestern University Feinberg School of Medicine discussed the reasons an adult with epilepsy may seek genetic testing and what benefits it can provide.
Latest:
Jennifer Robblee, MD: Adapting to Telemedicine in Migraine CareThe neurologist at the Barrow Neurological Institute gave her thoughts on how telemedicine has evolved throughout this year and its potential moving forward.
Latest:
Long-Term CBD Use Appears Safe for Patients With Lennox-Gastaut SyndromeThe section chief of pediatric neurology at Nationwide Children’s Hospital shared his excitement about the approval of Epidiolex and its potential as a therapeutic.
Latest:
Doctors, Remember Your CallingIt’s hard to be in medicine at the moment, and one day’s recognition is not enough. As your peer, I honor my fellow physicians today and every day.
Latest:
Tal Arbel, PhD: Approaching Multiple Sclerosis with Machine LearningThe director of the probabilistic vision group and medical imaging lab at McGill University spoke about how these learning methods can be used to predict future lesion activity and disability progression in MS.
Latest:
Steven Shook, MD: Managing Patients Via TelemedicineThe staff neurologist, Vice-Chair of Operations, and Quality Improvement Officer at Cleveland Clinic Neurological Institute detailed his experience managing patients with various conditions through a telemedicine platform.
Latest:
Aimee W. Smith, PhD: Caring for Pediatric Patients With EpilepsyThe assistant professor of psychology at East Carolina discussed how to improve adherence in young adults and children with epilepsy, and how physicians can go about checking quality of life in patients.
Latest:
Improving MS Diagnosis Through Biology and Early Detection: Wallace Brownlee, MBChB, PhD, FRACPAt ECTRIMS 2024, the consultant neurologist at Queen's Square MS Center in London talked about the evolving McDonald criteria to define multiple sclerosis biologically. [WATCH TIME: 5 minutes]
Latest:
Interdisciplinary Team Needed to Apply Machine Learning in Epilepsy Surgery: Lara Jehi, MD, MHCDSThe epilepsy specialist and Cleveland Clinic’s Chief Research and Information Officer detailed the steps and teamwork required to implement a machine learning that predicts seizure outcomes in epilepsy surgery. [WATCH TIME: 4 minutes]
Latest:
Manish Shah MD, MPH: How Telemedicine Can Reduce ED Use in DementiaThe professor of emergency medicine at the University of Wisconsin-Madison School of Medicine and Public Health spoke about how telemedicine in senior living communities can effectively decrease ED use by individuals with dementia.
Latest:
Rebecca Ichord, MD: Addressing Pediatric Stroke With Thrombectomy and ThrombolysisThe director of the Pediatric Stroke Program at CHOP discussed the findings of a single-center study exploring the incidence of children presenting with acute arterial ischemic stroke who may have been eligible for mechanical thrombectomy.
Latest:
AMX0035 in the ALS Treatment Paradigm: Sabrina Paganoni, MD, PhDThe investigator at the Healey & AMG Center for ALS at Massachusetts General Hospital spoke to the data backing the investigational AMX0035 in the treatment of ALS. [WATCH TIME: 3 minutes]
Latest:
CMSC 2021 Annual Meeting Takeaways: David Li, MD, FRCPCWith the CMSC 2021 annual meeting having wrapped up, the director of the Multiple Sclerosis/MRI Research Group at the University of British Columbia offered his perspective on this year’s conference. [WATCH TIME: 1 minute]
Latest:
CMSC Live: 2024 Annual Meeting Day 3Host Jeffrey Wilken, PhD, chats with Marijean Buhse, PhD, RN, NP-C, MSCN; Amy Sullivan, PsyD, ABPP; and John DeLuca, PhD, ABPP, FACRM, FAPA, FAPS, FNAN, about the third day of the 2024 CMSC Annual Meeting in Nashville, Tennessee.
Latest:
Ian Maidment, PhD: Treating Sleep Problems in Those with DementiaThe senior lecturer in Clinical Pharmacy at Aston University talked about issues facing the medical community in treating those with dementia who have sleep problems.
Latest:
Looking to the Future of Stroke Care: Protection and RestorationInterest in advancing research in stroke therapeutics has historically come in fits and starts. Now with intravenous tPA and thrombectomy in regular use, experts are looking to get a step ahead of the damage.
Latest:
Exploring CB1, CB2 in Various Neurological ConditionsCannabinoids are being explored in a variety of conditions, ranging from Alzheimer disease to migraine.
Latest:
Recommendations for RRMS ManagementAhmed Zayed Obeidat MD, PhD; Ravi Dukkipati, MD; and Gabriel Pardo, MD, FAAN, share key takeaways for clinicians treating RRMS.
Latest:
Daphne Chylinski: Arousals During Sleep Are Strongly Linked to Alzheimer Disease PathophysiologyChylinski spoke about the relationship between the increased number of arousals during sleep and the pathogenesis of Alzheimer disease.
Latest:
Biofluid Biomarkers Hold Promise for the Future of Huntington DiseaseCurrently, there are no disease-modifying medications for Huntington disease and few interventions available to effectively alleviate symptoms, while the lack of indicators of pathobiological processes at the molecular level has limited the ability to prove efficacy and safety in clinical trials.
